Literature DB >> 11501722

Esophageal involvement and pulmonary manifestations in systemic sclerosis.

I Marie1, S Dominique, H Levesque, P Ducrotté, P Denis, M F Hellot, H Courtois.   

Abstract

OBJECTIVE: To assess whether esophageal manometric motor disturbances are associated with abnormalities consistent with interstitial lung disease (ILD) on both pulmonary function tests (PFT) and high resolution computerized tomography (HRCT) scans in patients with systemic sclerosis (SSc), during initial evaluation and at 2 years followup.
METHODS: Esophageal manometry, PFT, and HRCT scans were performed in 43 consecutive SSc patients. PFT and HRCT scan parameters were compared between patients with severe esophageal motor dysfunction (i.e., aperistalsis and decreased low esophageal sphincter pressure), patients with moderate esophageal motor dysfunction (hypoperistalsis), and patients without esophageal motor dysfunction on manometry.
RESULTS: During initial evaluation of SSc, patients with severe esophageal motor impairment, compared with those with moderate and without esophageal dysmotility, exhibited significantly decreased median values of diffusing capacity for carbon monoxide (DLco) (68% vs. 94% vs. 104%) and exhibited higher prevalence of evidence for ILD on HRCT scan (57% vs. 27% vs. 18%). At 2 years followup of SSc, patients with severe esophageal motor disturbances, compared with those without, had faster deterioration of DLco median values (-16% vs. +1%) and higher frequency of ILD on HRCT scan (70% vs. 25%).
CONCLUSION: Our series underscores a correlation between the degree of esophageal manometric motor disturbances and evidence for ILD on PFT and HRCT scan in SSc patients, suggesting that gastroesophageal reflux (GER) may be one of the contributing factors of ILD in SSc. Our findings further indicate that patients with severe esophageal impairment may require closer followup of lung parameters. In turn, it suggests that aggressive therapy of GER should be initiated in these SSc patients, as it may result in decreased deterioration of pulmonary function.

Entities:  

Mesh:

Year:  2001        PMID: 11501722     DOI: 10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  38 in total

Review 1.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

2.  Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis.

Authors:  Shiko Kuribayashi; Sei-Ichiro Motegi; Kenichiro Hara; Yasuyuki Shimoyama; Hiroko Hosaka; Akiko Sekiguchi; Kouichi Yamaguchi; Osamu Kawamura; Takeshi Hisada; Osamu Ishikawa; Motoyasu Kusano; Toshio Uraoka
Journal:  J Gastroenterol       Date:  2019-04-01       Impact factor: 7.527

3.  Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations.

Authors:  Nurten Savas; Ulku Dagli; Esin Ertugrul; Sedef Kuran; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

4.  Predictors of inpatient mortality in patients with systemic sclerosis: a case control study.

Authors:  Shiv T Sehra; Andrew Kelly; Joshua F Baker; Chris T Derk
Journal:  Clin Rheumatol       Date:  2016-04-07       Impact factor: 2.980

5.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

6.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

Review 7.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

Review 8.  Imaging lung disease in systemic sclerosis.

Authors:  Diane Strollo; Jonathan Goldin
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

Review 9.  The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Authors:  Lesley Ann Saketkoo; Jeanette H Magnus; Mittie K Doyle
Journal:  Am J Med Sci       Date:  2014-01       Impact factor: 2.378

10.  Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment.

Authors:  Marco G Patti; Warren J Gasper; Piero M Fisichella; Ian Nipomnick; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.